(Catalog No
2 The minimum chain length required for 9B5-6-25-7 binding is approximately 20 oxyethylene units long (~ 1 kDa)
Lumigen SPARCL - Homogeneous Proximity Assay Technology by Lumigen, Inc
To our knowledge, this is the rst demonstration of the fully integrated homogeneous
The acronym, SPARCL (spatial proximity analyte reagent capture luminescence), implies that using this approach, an analyte in solution is detected and a
Lumigen ECL Ultra (TMA-6) US Patent No
A SPARCLTM IL-8 assay can be readily developed using commercially available antibodies and Lumigen SPARCL Detection Kit
Dilution of controls and the dilution ELISA AP Substrate Lumigen APS-5 is a proprietary acridan based chemiluminescent substrate for ELISA detection of alkaline phosphatase (AP) conjugated molecules
Life Diagnostics, Inc
We have previously shown the performance of the Omega microplate reader in detection of this luminescent assay
Coupled with oxidases, HyPerBlu allows one-step indirect detection of oxidases or SPARCL Generic Human IgG Pharmacokinetic Assay Kit (Lumigen) White, 384-well plates (Corning) White, 96-well plates (Greiner) Detection of SPARCL Immunoassays Using BMG LABTECH CLARIOstar SPARCL™ for Antibody Screening
Lumigen HyPerBlu ® Data Sheet Application Instructions Handling Instructions Scientific Poster
Lumigen ECL Ultra (TMA-6) is a proprietary acridan based chemiluminescent substrate for ultra-sensitive detection of Western blotted and ELISA captured proteins that are bound to horseradish peroxidase (HRP) labeled antibodies
Long stability of the formulation combined with
About Us
8 μl) was mixed in an amber vial with 120 μl of the capture antibody (1 mg ml −1) from the DuoSet® System and 340
Reaction of the substrate with hydrogen peroxide rapidly generates sustained high intensity luminescence for maximum detection sensitivity in solution assays
SPARCL produces only 1x well volume of waste compared to 13x well volume for conventional ELISA assays